Spinal Therapy Co. Ducks Investor Class Action
A Massachusetts federal judge on Friday threw out a putative class action against a biotechnology firm accused of deceiving investors about the timeline for human testing on a spinal cord treatment,...To view the full article, register now.
Already a subscriber? Click here to view full article